The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants

Vaccine

Volumn 36, Issue 2, 2018, Pages 273-279

  Lazarus, Robin P ^a   John, Jacob ^a   Shanmugasundaram, E ^a   Rajan, Anand K ^a   Thiagarajan, S ^a   Giri, Sidhartha ^a   Babji, Sudhir ^a   Sarkar, Rajiv ^a   Kaliappan, P Saravankumar ^a   Venugopal, Srinivasan ^a   Praharaj, Ira ^a   Raman, Uma ^a   Paranjpe, Meghana ^a   Grassly, Nicholas C ^b   Parker, Edward P K ^b   Parashar, Umesh D ^c   Tate, Jacqueline E ^c   Fleming, Jessica A ^d   Steele, A Duncan ^e   Muliyil, Jayaprakash ^a   Abraham, Asha M ^a   Kang, Gagandeep ^a   more..

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PATH   (United States)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

India; Lactobacillus GG; Poliovirus vaccine; Rotavirus vaccines; Zinc

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; PLACEBO; PROBIOTIC AGENT; PROTEIN VP6; ROTAVIRUS VACCINE; ZINC SULFATE; IMMUNOGLOBULIN A; LIVE VACCINE; RIX4414 VACCINE; VIRUS ANTIBODY; ZINC;

ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FEMALE; HUMAN; IMMUNOGENICITY; INDIAN; INFANT; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; VIRUS SHEDDING; ZINC BLOOD LEVEL; BLOOD; IMMUNOLOGY; INDIA; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN A; INDIA; INFANT; LACTOBACILLUS RHAMNOSUS; MALE; PLACEBOS; PROBIOTICS; ROTAVIRUS VACCINES; TREATMENT OUTCOME; VACCINES, ATTENUATED; ZINC;

EID: 85028687174     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.07.116     Document Type: Article

References (38)

1. Tate, J.E., Burton, A.H., Boschi-Pinto, C., Parashar, U.D., Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clinical Infect Dis 62 (2016), S96–S105.
2. John, J., Sarkar, R., Muliyil, J., Bhandari, N., Bhan, M.K., Kang, G., Rotavirus gastroenteritis in India, 2011–2013: revised estimates of disease burden and potential impact of vaccines. Vaccine 32:Suppl 1 (2014), A5–A9.
3. Patel, M.M., Parashar, U.D., Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 200:Suppl 1 (2009), S291–S299.
4. Patriarca, P.A., Wright, P.F., John, T.J., Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13 (1991), 926–939.
5. Parashar, U.D., Johnson, H., Steele, A.D., Tate, J.E., Health impact of rotavirus vaccination in developing countries: progress and way forward. Clinical Infect Dis 62:Suppl 2 (2016), S91–S95.
6. Groome, M.J., Zell, E.R., Solomon, F., Nzenze, S., Parashar, U.D., Izu, A., et al. Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa. Clin Infect Dis 62:Suppl 2 (2016), S188–S195.
7. Mpabalwani, E.M., Simwaka, C.J., Mwenda, J.M., Mubanga, C.P., Monze, M., Matapo, B., et al. Impact of rotavirus vaccination on diarrheal hospitalizations in children aged <5 years in Lusaka, Zambia. Clin Infect Dis 62:Suppl 2 (2016), S183–S187.
8. Patel, M., Glass, R.I., Jiang, B.M., Santosham, M., Lopman, B., Parashar, U., A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis 208 (2013), 284–294.
9. Bhandari, N., Rongsen-Chandola, T., Bavdekar, A., John, J., Antony, K., Taneja, S., et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet, 2014.
10. Narang, A., Bose, A., Pandit, A.N., Dutta, P., Kang, G., Bhattacharya, S.K., et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Hum Vaccine 5 (2009), 414–419.
11. Serazin, A.C., Shackelton, L.A., Wilson, C., Bhan, M.K., Improving the performance of enteric vaccines in the developing world. Nat Immunol 11 (2010), 769–773.
12. Kazi, A.M., Cortese, M.M., Yu, Y., Lopman, B., Morrow, A.L., Fleming, J.A., et al. Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants. J Infect Dis 215 (2017), 786–789.
13. Valdezi, Y., Brown, E.M., Finlay, B.B., Influence of the microbiota on vaccine effectiveness. Trends Immunol 35 (2014), 526–537.
14. Pfeiffer, J.K., Virgin, H.W., Transkingdom control of viral infection and immunity in the mammalian intestine. Science, 351, 2016, 239.
15. Keusch, G.T., Denno, D.M., Black, R.E., Duggan, C., Guerrant, R.L., Lavery, J.V., et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 59 (2014), S207–S212.
16. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2015. https://doi.org/10.1016/j.ebiom.2015.09.036.
17. Grassly, N.C., Praharaj, I., Babji, S., Kaliappan, S.P., Giri, S., Venugopal, S., et al. The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants. Lancet Infect Dis 16 (2016), 905–914.
18. Praharaj, I., John, S.M., Bandyopadhyay, R., Kang, G., Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc B – Biol Sci, 370, 2015, 12.
19. Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M., Vesikari, T., Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13 (1995), 310–312.
20. Maidens, C., Childs, C., Przemska, A., Bin Dayel, I., Yaqoob, P., Modulation of vaccine response by concomitant probiotic administration. Br J Clin Pharmacol 75 (2013), 663–670.
21. Sindhu, K.N., Sowmyanarayanan, T.V., Paul, A., Babji, S., Ajjampur, S.S., Priyadarshini, S., et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis: Off Publ Infect Dis Soc Am 58 (2014), 1107–1115.
22. Akhtar, S., Zinc status in South Asian populations – an update. J Health Popul Nutr 31 (2013), 139–149.
23. Fraker, P.J., King, L.E., Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 24 (2004), 277–298.
24. Savy, M., Edmond, K., Fine, P.E.M., Hall, A., Hennig, B.J., Moore, S.E., et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr 139 (2009), 2154S–2218S.
25. Habib, M.A., Soofi, S., Sheraz, A., Bhatti, Z.S., Okayasu, H., Zaidi, S.Z., et al. Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial. Vaccine 33 (2015), 819–825.
26. Ahmed, T., Svennerholm, A.M., Al Tarique, A., Sultana, G.N., Qadri, F., Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 27 (2009), 1433–1439.
27. Albert, M.J., Qadri, F., Wahed, M.A., Ahmed, T., Rahman, A.S., Ahmed, F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 187 (2003), 909–913.
28. Karlsen, T.H., Sommerfelt, H., Klomstad, S., Andersen, P.K., Strand, T.A., Ulvik, R.J., et al. Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation. Infect Immun 71 (2003), 3909–3913.
29. Sur, D., Gupta, D.N., Mondal, S.K., Ghosh, S., Manna, B., Rajendran, K., et al. Impact of zinc supplementation on diarrheal morbidity and growth pattern of low birth weight infants in Kolkata, India: a randomized, double-blind, placebo-controlled, community-based study. Pediatrics 112 (2003), 1327–1332.
30. Ward, R.L., Bernstein, D.I., Smith, V.E., Sander, D.S., Shaw, A., Eiden, J.J., et al. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. J Infect Dis 189 (2004), 2290–2293.
31. World Health Organization. Polio laboratory manual, 4th ed. Geneva: WHO/IVB/04.10; 2004.
32. Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine 2018;36(2):264–72.
33. Newcombe, R.G., Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 17 (1998), 2635–2650.
34. Ramani, S., Mamani, N., Villena, R., Bandyopadhyay, A.S., Gast, C., Sato, A., et al. Rotavirus serum IgA immune response in children receiving Rotarix coadministered with bOPV or IPV. Pediatr Infect Dis J, 35, 2016.
35. Emperador, D.M., Velasquez, D.E., Estivariz, C.F., Lopman, B., Jiang, B., Parashar, U., et al. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis 62 (2016), 150–156.
36. Glass R, Bresee J, Jiang B, Parashar U, Yee E, Gentsch J. Rotavirus and rotavirus vaccines. In: Pollard A, Finn A, editors. Hot topics in infection and immunity in children III. Springer US; 2006. p. 45–54.
37. Jiang, V., Jiang, B., Tate, J., Parashar, U.D., Patel, M.M., Performance of rotavirus vaccines in developed and developing countries. Hum Vaccine 6 (2010), 532–542.
38. Shin SAD, Zaman K, Yunus M, Mai le TP, Thiem VD, Azim T, et al. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine 2012;30:A106–13.